DENVER, Colo., Oct. 27, 2023 (www.247marketnews.com)- The following companies were among the listings that we covered this week;
We didn’t like how the market was trading, but covered INVO Bioscience (NASDAQ: INVO) when it was at $1.91, up $1.37 (+253.70%), on 22.97M shares traded. We were going to cover it in the premarket, when it was at about $1.50, and finally did a little after the regular session open. It hit a high of $3.04 and could have been extra special, but the many trading halts finally killed its rally. It closed at $2.12, up $1.58 (+292.59%), on 106,279,966 shares traded.
We also covered Webuy Global (NASDAQ: WBUY) when it was trading at $3.70, up $0.55 (+17.31%), on 227.06K shares traded. It hit $4.9751 and closed near that high at $4.94, up $0.81 (+19.61%), on trading volume of 299,099 shares.
The last momo that we covered was Akumin Inc (NASDAQ: AKU), which was trading at $0.34, up $0.19 (+129.77%), around noon, on 82.19M shares traded. It popped and hit its $0.499 high about an hour later, then closed at $0.357, up $0.2112 (+144.86%), on trading volume of 141,158,565 shares.
Despite being a travel day, we were able to cover LianBio’s (NASDAQ: LIAN) deal with Bristol Myers Squibb (NYSE: BMY) for total upfront consideration of $350 million, to develop and commercialize mavacamten in six Asian markets, when LianBio was trading at $2.20, up $0.81 (+58.27%), on 384.6K premarket shares traded.
It hit $4 in the premarket, dropped to open the regular session at $2.50, where it took an hour to get back to the $3 level, which became the floor for the rest of the day. The regular session high was $3.49 and it closed at $3.02, up $1.63 (+117.27%), on trading volume of 92,818,694 shares.
Today, it hit $4.28 and closed at $3.90, up $0.13 (+3.45%), on 5,694,644 shares traded.
We spotted that Reshape Lifesciences (NASDAQ: RSLS) was active in premarket trading when it was at $0.279, up $0.19 (+212.56%), on 27.29M premarket shares traded. It hit a high of $0.3539, but couldn’t hold it, as it dropped to close at $0.25, up $0.0443 (+21.54%), on trading volume of 69,236,693 shares/
TransCode Therapeutics (NASDAQ: RNAZ) reported improved survival in mice implanted with human GBM tumors treated with TTX-MC138 survived significantly longer than those in the control group. It was trading at $0.43, up $0.06 (+15.90%), on 561.6K premarket shares traded when we covered it and it hit a premarket high of $0.5476 and traded 12.66M premarket shares, but it couldn’t match the price action in the regular session.
ABVC BioPharma (NASDAQ: ABVC) entered into a binding term sheet regarding a multi-year, global licensing agreement with AiBtl BioPharma for the Company’s CNS drugs for $667M. We covered the news when it was trading at $1.33, up $0.48 (+56.47%), on 429.9K premarket shares traded. It hit a premarket high of $3.93 and traded 14.18M shares, before opening the regular session at $3.31. It too couldn’t match the premarket price action and topped out at $3.35, before closing at $1.28, $0.43 (+50.59%), on trading volume of 82,234,139 shares. Considering that it set its all-time trading volume record, the regular session price action was especially disappointing.
SeaStar Medical (NASDAQ: ICU) was making a premarket move, which we covered when it was trading at $1.06, up $0.268 (+33.84%), on 1.38M premarket shares. It reached $1.23 in the premarket, but could only reach $1.18 in the regular session.
BIO-key International Inc (NASDAQ: BKYI) reported that ALPI Portugal Lda. deployed BIO-key’s AuthControl Sentry solution when it was trading at $0.235, up $0.0643 (+37.67%) 136.8K premarket shares traded. It hit a premarket high of $0.4311 and traded 9,087,880 premarket shares.
We covered that Nerdwallet Inc (NASDAQ: NRDS) was trading at $8.14, up $1.50 (+22.59%), on 104.7K shares, after reporting third quarter results Thursday evening. It hit a high of $9.82 before closing $9.34, up $2.70 (+40.66%), on trading volume of 7,655,702 shares.
We’re still not thrilled with the market action, so we’re covering less listings.
Thank you for joining us this week. Have a great weekend and get ready for next week!
Connect with 24/7 Market News:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
24/7 Market News